Approval · Notice of Compliance 35914 · 2025
INFLUVAC: Notice of Compliance 35914
Issued August 27, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35914
- Date
- August 27, 2025
- Company
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Annual update – strain changes
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INFLUVAC | Not yet assigned | — |
Medicinal ingredients
- NEURAMINIDASE ANTIGEN 0.1 UNIT per 0.5ML
- HAEMAGGLUTININ 15 MCG per 0.5ML